Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAUTICAL: Sacubitril/Valsartan for Cardiometabolic Health in Black Individuals
NCT04055428Phase 2Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Aug 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sacubitril + valsartan in insulin resistance (IR), sponsored by University of Alabama at Birmingham. Started Aug 2020; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT04055428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04055428.